Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone. For countries like Estonia and the US, it entailed boosting telehealth services. For
Read MoreBringing pharmaceutical weed to telehealth, medical cannabis company Vitura Health (ASX: VIT) has decided to acquire telehealth company Doctors on Demand for an aggregate consideration of $25 million. This deal includes an upfront cash payment, a deferred cash component, and an equity stake. The acquisition marks Vitura’s leap into new healthcare verticals, including urgent care,
Read MoreSince launching its Mixed Clinical Workforce program in June 2023, telehealth company Doctor Care Anywhere (ASX: DOC) has expanded its capacity to serve customers, ultimately contributing to margin expansion and growth potential. For the three months ended 30 September 2023, Doctor Care Anywhere’s telehealth platform delivered 180,700 consultations during the quarter, marking a 29.8% increase
Read MoreIn times of illness, the last thing you would want to do is to venture out to a clinic packed with other fellow sick individuals. Plus, the idea of enduring lengthy queues for a doctor’s appointment won’t bring any good for your recovery. With technology integrated into the medical field, patients now have greater control
Read MoreIn the post-pandemic world, home-based medical tests and remote healthcare consultations are becoming the preferred method due to it being relatively effective (say bye to hours of waiting time in clinics!), and accessible. This is especially true for those located in rural areas, where telehealth is becoming a new norm that will continue to change
Read MoreWith a super on-the-nose name, it’s difficult not to know what UK-based telehealth company Doctor Care Anywhere (ASX: DOC) does. Providing people consultations no matter where they are, the Company seems to have received public favour, with a spurt in the number of returning customers and thriving subsidiaries. At the same time, this was probably
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.